Valsartan NDMA Blood Pressure Drug Cancer Lawsuit MDL 2875: 2026 Claimant Guide
Complete guide to the valsartan, losartan, and irbesartan NDMA/NDEA contamination cancer lawsuit MDL 2875 in New Jersey: 2018 FDA recall, 1,246 recalled lots, Zhejiang Huahai/Mylan/Teva/Aurobindo defendants, cancer types claimed, eligibility criteria, and statutes of limitations by state.
MDL 2875 valsartan lawsuit NDMA
